Stanford University
Showing 28,801-28,850 of 36,202 Results
-
Josh Shiode
Managing Director, KIPAC
BioJosh Shiode is Managing Director of the Kavli Institute for Particle Astrophysics and Cosmology (KIPAC), a joint institute of Stanford University and the SLAC National Laboratory. Prior to joining KIPAC, Josh served as Senior Advisor and Chief of Staff in the U.S. Department of Energy Office of Science, under the leadership of then Director Asmeret Asefaw Berhe. Josh received his PhD in astrophysics from UC Berkeley in 2013, and subsequently worked in a variety of science and technology policy roles in Washington, DC, including with the American Association for the Advancement of Science and the Pacific Northwest National Laboratory.
-
Parveen Shiraz, MD
Instructor, Medicine - Blood & Marrow Transplantation
Current Research and Scholarly InterestsI am a physician-scientist in the Division of Blood and Marrow Transplantation-Cell Therapy (BMT-CT) at Stanford University. The focus of my laboratory research is the exploration of safe and more accessible forms of cell therapy for myeloid malignancies. We are studying multi-antigen targeting antibodies and engineered Natural Killer cells for myeloid malignancies.
-
Judith Shizuru
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsTransplantation of defined populations of allogeneic hematopoietic cells. Specifically, the way in which hematopoietic cell grafts alter antigen specific immune responses to allo-, auto- and viral antigens. The cellular and molecular basis of resistance to engraftment of allogeneic hematopoietic stem cells.
-
Eugene Shkolyar, MD
Clinical Assistant Professor, Urology
BioEugene Shkolyar, MD is a urologic oncologist who specializes in treating patients with bladder, prostate, kidney, and testis cancers. He is a clinical assistant professor in the Department of Urology at the Stanford School of Medicine.
Dr. Shkolyar has expertise in open, endoscopic, and robotic surgery and in caring for patients with complex urologic oncology needs. Dr. Shkolyar is actively engaged in translational research, with a particular interest in integrating artificial intelligence into bladder cancer treatment and the development of novel biomarkers for cancer detection. His commitment to continual innovation ensures that his patients have access to the latest and most effective treatment options.
Dr. Shkolyar was born in Kyiv, Ukraine, and raised in New York. He attended Cornell University for his undergraduate education and went on to UCLA for medical school. Following medical school, Dr. Shkolyar completed a residency in urology at Stanford, where he developed his interest in urologic oncology, translational bladder cancer research and teaching. He went on to complete a two-year fellowship in urologic oncology at Stanford School of Medicine gaining additional skills in management of complex urologic cancers. Dr. Shkolyar is the recipient of numerous honors and awards, including membership in the Alpha Omega Alpha medical honors society and a research scholar award from the Urology Care Foundation. In addition, he has authored and co-authored numerous publications in urology, artificial intelligence, and device development.
Dr. Shkolyar is a member of the Society of Urologic Oncology, the American Society of Clinical Oncology, the American Urological Association, and the European Association of Urology. -
Yoav Shoham
Professor of Computer Science, Emeritus
BioYoav Shoham is professor emeritus of computer science at Stanford University. A leading AI expert, Prof. Shoham is Fellow of AAAI, ACM and the Game Theory Society. Among his awards are the IJCAI Research Excellence Award, the AAAI/ACM Allen Newell Award, and the ACM/SIGAI Autonomous Agents Research Award. His online Game Theory course has been watched by close to a million people. Prof. Shoham has founded several AI companies, including TradingDynamics (acquired by Ariba), Katango and Timeful (both acquired by Google), and AI21 Labs. Prof. Shoham also chairs the AI Index initiative (www.AIindex.org), which tracks global AI activity and progress, and WeCode (www.wecode.org.il), a nonprofit initiative to train high-quality programmers from disadvantaged populations.
-
William Shomali
Clinical Assistant Professor, Medicine - Hematology
BioDr. Shomali is a clinical assistant professor of Hematology at Stanford University School of Medicine. He is board certified in hematology & medical oncology.
Dr. Shomali specializes in the treatment of blood cancers such as myeloproliferative neoplasms and myelodysplastic syndromes. He aims to provide compassionate, personalized, and evidence-based care to each patient.
Dr. Shomali received his medical degree from the University of Jordan, followed by a postdoctoral fellowship at MD Anderson Cancer Center where he studied infections in cancer patients and the role of biomarkers in defining tumor fever. He completed his residency training in Internal Medicine at the Cleveland Clinic Foundation where he served as a Chief Medical Resident. He then joined Stanford University for his combined Hematology & Oncology fellowship training.
Dr. Shomali’s research interests include the study of novel agents in myeloproliferative neoplasms and myelodysplastic syndromes. He developed investigator-initiated clinical trials for patients with eosinophilic neoplasms and advanced myelofibrosis. In addition, he co-authored several papers and book chapters discussing the care of patients with cancer. His work has been presented in national meetings and published in peer reviewed journals including Blood, American Journal of Hematology, British Journal of Hematology, Leukemia & Lymphoma, and Cancer.
Among his honors, Dr. Shomali received the Cleveland Clinic Excellence in Teaching Award and was named to the Alpha Omega Alpha Medical Honor Society. He has received a Young Investigator Award from the Conquer Cancer Foundation, an NIH Institutional National Research Service Award, and a Stanford Cancer Institute Fellowship Award.
Dr. Shomali is a member of the American Society of Hematology and the American Society of Clinical Oncology. -
Mahasish Shome
Postdoctoral Scholar, Genetics
BioDr. Mahasish Shome is interested in understanding the underlying mechanism of disease progression. He uses various omics profiling to identify biomarkers relevant to the disease. He studies antibodies, cytokines, proteins and microbiome profile to decipher the connection of disease with markers. Connecting various omics provide a holistic overview of the disease profile and can help in early diagnosis, understanding disease state and drug/vaccine effectiveness.
-
Stanford Shoor
Clinical Professor, Medicine - Immunology & Rheumatology
Current Research and Scholarly InterestsPatient Centered Care in Rheumatic Disease
Sarcoidosis -
Jade Shorter, MD, MSHP
Clinical Associate Professor, Obstetrics & Gynecology
BioDr. Shorter specializes in complex family planning, early pregnancy management, and general gynecology. She is committed to improving the continuity of care for patients with early pregnancy complications and serves as the Director of the Early Pregnancy Assessment Program. Her clinical research interests include improving patients’ experience with abortion and early pregnancy care, addressing reproductive health disparities, and promoting health equity.
-
Linda M. Dairiki Shortliffe
Stanley McCormick Memorial Professor in the School of Medicine, Emerita
Current Research and Scholarly InterestsThe timing for intervention in obstruction in the infant and child is poorly understood.Our group has been interested in trying to define the risks that may be involved in obstructive and infectious uropathies and discovering early signs of damage to the urinary tract and kidney. We have explored ways of imaging the urinary tract using nonionizing radiation (US, MRI). We have studied the relationships of sex steroid hormones, pregnancy, reflux, urinary tract infection and urinary tract function.
-
John Shoven
The Charles Schwab Professor of Economics, Emeritus
BioJohn B. Shoven is the Trione Director of the Stanford Institute for Economic Policy Research and the Charles R. Schwab Professor of Economics at Stanford. He is also a Senior Fellow at the Hoover Institution and a Research Associate of the National Bureau of Economic Research. He specializes in public finance and corporate finance and has published on Social Security, health economics, corporate and personal taxation, mutual funds, pension plans, economic demography and applied general equilibrium economics. His books include The Real Deal: The History and Future of Social Security, Yale University Press, 1999 and The Evolving Pension System, Brookings Institution Press, 2005. His most recent book is co-authored with former Secretary of State and Treasury George Shultz and deals with both Social Security and health care reform in the U.S. (Putting Our House in Order: A Guide to Social Security and Health Care Reform, WWNorton, 2008). He also recently published a research paper on new ways of measuring age (“New Age Thinking: Alternative Ways of Measuring Age, Their Relationship to Labor Force Participation, Government Policies and GDP,” NBER Working Paper No. 13476. October 2007). His journal publications appear in such places as the American Economic Review, Journal of Economic Perspectives, and the Journal of Public Economics. In total, he has published more than one hundred professional articles and twenty books.
Professor Shoven is a Fellow of the American Academy of Arts and Sciences, a recipient of the Paul A. Samuelson Award for Outstanding Scholarly Writing on Lifelong Financial Security, and an award winning teacher at Stanford. He received his Ph.D in Economics from Yale University in 1973 and has been associated with Stanford ever since. He was Dean of Humanities and Sciences from 1993 to 1998. He is Chairman of the Board of Board of Cadence Design Systems and serves on the boards of American Century Funds, Exponent, Inc. and Financial Engines, Inc. -
Talya Shragai
Research and Program Manager, Disease Ecology in a Changing World, Human and Planetary Health
Current Role at StanfordResearch and Program Manager - Disease Ecology in a Changing World
-
Joseph Shrager
Professor of Cardiothoracic Surgery
Current Research and Scholarly InterestsIn clinical research, Dr. Shrager studies outcomes in a variety of areas within Thoracic Surgery including: parenchyma-sparing operations and minimally invasive resections for lung cancer, transcervical thymectomy for myasthenia gravis, diaphragm plication, and surgical treatment of emphysema.
Dr. Shrager's lab is focused on the impact of disease states upon the diaphragm. His group published the seminal paper (NEJM) describing diaphragm atrophy assoc'd with mechanical ventilation.
